Literature DB >> 17355776

Laparoscopically implanted gastric pacemaker after kidney-pancreas transplantation: treatment of morbid obesity and diabetic gastroparesis.

Hugo Bonatti1, Gerald Brandacher, Elisabeth Hoeller, Ingrid Stelzmueller, Walter Mark, Raimund Margreiter, Helmut Weiss.   

Abstract

Combined kidney-pancreas transplantation is the treatment of choice for end-stage diabetic nephropathy. Weight gain post-transplant increases the risk for post-transplant complications and death due to cardiovascular events. Gastric pacemakers have been used for therapy of diabetic gastropathy and for the treatment of moderate morbid obesity. We report a patient who experienced significant weight gain following successful kidney-pancreas transplantation and was thereafter successfully treated for diabetic gastroparesis and morbid obesity by use of a laparoscopically implanted gastric pacemaker.

Entities:  

Mesh：

Year:  2007        PMID： 17355776     DOI： 10.1007/s11695-007-9013-6

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   4.129


  14 in total

1.  Diabetic and Nondiabetic Gastroparesis.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1998-12

2.  Technical failures after pancreas transplants: why grafts fail and the risk factors--a multivariate analysis.

Authors:  Abhinav Humar; Thigarajan Ramcharan; Raja Kandaswamy; Rainer W G Gruessner; Angelika C Gruessner; David E R Sutherland
Journal:  Transplantation       Date:  2004-10-27       Impact factor: 4.939

3.  Type II diabetes after combined kidney and pancreas transplantation for type I diabetes mellitus and end-stage renal disease.

Authors:  J W Jones; S S Mizrahi; F R Bentley
Journal:  Clin Transplant       Date:  1996-12       Impact factor: 2.863

Review 4.  Implantable electrical gastric stimulation to treat morbid obesity in the human: operative technique.

Authors:  Karl A Miller
Journal:  Obes Surg       Date:  2002-04       Impact factor: 4.129

5.  Gastric pacing is a new surgical treatment for gastroparesis.

Authors:  J Forster; I Sarosiek; R Delcore; Z Lin; G S Raju; R W McCallum
Journal:  Am J Surg       Date:  2001-12       Impact factor: 2.565

6.  Gastric bypass in morbidly obese patients with chronic renal failure and kidney transplant.

Authors:  J Wesley Alexander; Hope R Goodman; Keith Gersin; Michael Cardi; Joe Austin; Sharad Goel; Shahzad Safdar; Shaoming Huang; E Steve Woodle
Journal:  Transplantation       Date:  2004-08-15       Impact factor: 4.939

7.  Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation.

Authors:  Zhiyue Lin; Jameson Forster; Irene Sarosiek; Richard W McCallum
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

8.  Further experience with gastric stimulation to treat drug refractory gastroparesis.

Authors:  Jameson Forster; Irene Sarosiek; Zhiyue Lin; Sara Durham; Suzanne Denton; Katherine Roeser; Richard W McCallum
Journal:  Am J Surg       Date:  2003-12       Impact factor: 2.565

9.  "What are the yanks doing?" the U.S. experience with implantable gastric stimulation (IGS) for the treatment of obesity - update on the ongoing clinical trials.

Authors:  Scott A Shikora
Journal:  Obes Surg       Date:  2004-09       Impact factor: 4.129

10.  Obesity as a risk factor after combined pancreas/kidney transplantation.

Authors:  G L Bumgardner; M L Henry; E Elkhammas; G A Wilson; P Tso; E Davies; W Qiu; R M Ferguson
Journal:  Transplantation       Date:  1995-12-27       Impact factor: 4.939
View more
  1 in total

1.  Protracted Hypocalcemia following 3.5 Parathyroidectomy in a Kidney Pancreas Recipient with a History of Robotic-Assisted Roux-en-Y Gastric Bypass.

Authors:  Hugo Bonatti; Naureen Iqbal; Catherine Kling; Willie Melvin; James Broome
Journal:  Case Rep Transplant       Date:  2018-07-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.